Through its subsidiary Olerup Allenex has decided to extend the agreement with the Australian company Conexio Genomics.
Allenex announced a five year exclusive and global marketing and sales agreement with Conexio back in 2011 for SBT Resolver for HLA typing using the SBT technology. Software for sequence analysis had also been included in the agreement.
Conexio and Allenex now extends the agreement for another two years, until at least April 2018. Allenex has also been granted the right to market and sell three new products from Conexio; GammaType, MPS Resolver, Next Generation Sequencing (NGS) HLA products and another new NGS product with proprietary rights. Software for sequence analysis is also included. All products will be added to Allenex product portfolio from 2014 and in the years to come.
Allenex will waive its exclusive rights under the agreement for certain selected Asian market such as Singapore, Malaysia, Indonesia, Thailand, Vietnam, Cambodia, Hong Kong and Japan, in order to focus on those other markets where the parties see the greatest potential. Allenex will, however, retain non-exclusive rights to distribute in these countries. Allenex retains its exclusive distribution rights in Europe, North and South America, the Middle East, Africa and parts of Asia under the Agreement. Australia, New Zealand and Taiwan have previously been excluded from the co-operation and Allenex will not have distribution rights in these markets according to the new agreement either.